Raymond James Downgrades Hospira (HSP) to Market Perform
HSP Hot Sheet
Rating Summary:5 Buy, 8 Hold, 2 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 16 | Down: 7 | New: 23
Raymond James downgraded Hospira (NYSE: HSP) from Outperform to Market Perform.
For an analyst ratings summary and ratings history on Hospira click here. For more ratings news on Hospira click here.
Shares of Hospira closed at $30.14 yesterday, with a 52 week range of $26.92-$59.20.
Discover Wall Street's best ratings calls with the pros - Upgrade to Ratings Insider Elite. Free Trial!
For an analyst ratings summary and ratings history on Hospira click here. For more ratings news on Hospira click here.
Shares of Hospira closed at $30.14 yesterday, with a 52 week range of $26.92-$59.20.
Discover Wall Street's best ratings calls with the pros - Upgrade to Ratings Insider Elite. Free Trial!
You May Also Be Interested In
- UPDATE: UBS Downgrades Wisconsin Energy (WEC) to Neutral; Taking Some Off The Table
- BMO Capital Downgrades Human Genome Sciences (HGSI) to Market Perform
- Canaccord Genuity Maintains a 'Hold' on Tiffany & Co. (TIF); Cutting PT and Estimates
Create E-mail Alert Related Categories
DowngradesRelated Entities
Raymond JamesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
